Please login to the form below

Not currently logged in
Email:
Password:

AiCuris

This page shows the latest AiCuris news and features for those working in and with pharma, biotech and healthcare.

EC grants MSD’s Prevymis orphan product designation

EC grants MSD’s Prevymis orphan product designation

The treatment - which MSD acquired from German biotech AiCuris - has already been approved for use in the same disease indication for the US last year.

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2012 Pharma deals during October 2012

    The $142m upfront payment representing approximately 25 per cent of the consideration is certainly attractive for AiCuris and probably reflects the fact that this drug is for an orphan indication. ... 587. AiCuris / Merck &Co. Licence. Letermovir (phase

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • TiGenix appoints Dr Marie Paule Richard TiGenix appoints Dr Marie Paule Richard

    TiGenix appoints Dr Marie Paule Richard. She takes on role as chief medical officer and brings experience from Aicuris and Crucell. ... An immunologist with over 25 years of experience in the global biopharmaceutical industry, Richard has previously

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics